UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

Reduction of endoplasmic reticulum- mitochondria interactions in beta cells from patients with type 2 diabetes

PloS one, 2017-07, Vol.12 (7), p.e0182027-e0182027

2017

Link zum Volltext

Verfügbarkeit prüfen

Hope, hype and present limitations of hybrid closed loop systems for persons with type 1 diabetes

Diabetes & metabolism, 2024-03, Vol.50 (2), p.101510-101510, Article 101510

Thivolet, Charles

2024

Link zum Volltext

Verfügbarkeit prüfen

Human Pancreatic Islets React to Glucolipotoxicity by Secreting Pyruvate and Citrate

Nutrients, 2023-11, Vol.15 (22), p.4791

2023

Link zum Volltext

Verfügbarkeit prüfen

Performance and patients’ satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study

PloS one, 2023-08, Vol.18 (8), p.e0289684-e0289684

2023

Link zum Volltext

Verfügbarkeit prüfen

Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration

Diabetes technology & therapeutics, 2013-07, Vol.15 (7), p.601

2013

Link zum Volltext

Verfügbarkeit prüfen

miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes

Journal of diabetes research, 2016-01, Vol.2016, p.1869082-7

2016

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3

Diabetes care, 2009, Vol.32 (1), p.160-164

2009

Link zum Volltext

Verfügbarkeit prüfen

Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations

Diabetes & metabolism, 2021-11, Vol.47 (6), p.101290-101290, Article 101290

Thivolet, Charles

2021

Link zum Volltext

Verfügbarkeit prüfen

Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening

Trials, 2011-01, Vol.12 (1), p.23-23, Article 23

2011

Link zum Volltext

Verfügbarkeit prüfen

Prise de position de la Société francophone du diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2 - 2021

Médecine des maladies métaboliques, 2021-12, Vol.15 (8), p.779-780

Thivolet, Charles

2021

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a Type 1 and Type 2 diabetes-specific patient-reported experience measure e-questionnaire: Diabetes reported experience measures (DREMS)

Diabetes epidemiology and management, 2024-01, Vol.13, p.100189, Article 100189

2024

Link zum Volltext

Verfügbarkeit prüfen

Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway

The FASEB journal, 2013-12, Vol.27 (12), p.5122-5130

2013

Link zum Volltext

Verfügbarkeit prüfen

Histoire naturelle des cellules bêta au cours du diabète de type 1 : conséquences cliniques et possibilités thérapeutiques

Médecine des maladies métaboliques, 2020-12, Vol.14 (8), p.732-737

Thivolet, Charles

2020

Link zum Volltext

Verfügbarkeit prüfen

Bilateral vertebral artery dissection revealing Cushing's syndrome

Annales d'endocrinologie, 2019-02, Vol.80 (1), p.67-69

2019

Link zum Volltext

Verfügbarkeit prüfen

Évaluer le ressenti des hypoglycémies chez des personnes vivant avec un diabète de type 1 reste toujours nécessaire en pratique clinique

Médecine des maladies métaboliques, 2023-06, Vol.17 (4), p.345-350

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports

Diabetes & metabolism, 2020-09, Vol.46 (4), p.265-271

2020

Link zum Volltext

Verfügbarkeit prüfen

Reduction of endoplasmic reticulummitochondria interactions in beta cells from patients with type 2 diabetes

PloS one, 2017-07

2017

Link zum Volltext

Verfügbarkeit prüfen

Comment on Šoupal et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-up From the COMISAIR Study. Diabetes Care 2020;43:37-43

Diabetes care, 2020-04, Vol.43 (4), p.e52-e53

2020

Link zum Volltext

Verfügbarkeit prüfen

Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide

Diabetologia, 2019-04, Vol.62 (4), p.593-597

2019

Link zum Volltext

Verfügbarkeit prüfen

Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216-224

Diabetes care, 2024-05, Vol.47 (5), p.e44

2024

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Diabetologia, 2020-08, Vol.63 (8), p.1500-1515

2020

Link zum Volltext

Verfügbarkeit prüfen

Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics

Diabetes, obesity & metabolism, 2024-02, Vol.26 (2), p.557-566

2024

Link zum Volltext

Verfügbarkeit prüfen

Comment on Šoupal et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-up From the COMISAIR Study. Diabetes Care 2020;43:37–43/ Reply

Diabetes care, 2020-04, Vol.43 (4), p.e52

2020

Link zum Volltext

Verfügbarkeit prüfen

A Cholera Toxoid-Insulin Conjugate as an Oral Vaccine against Spontaneous Autoimmune Diabetes

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (9), p.4610-4614

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(104)
Humans
(95)
Life Sciences
(80)
Endocrinology & Metabolism
(68)
Female
(67)
Male
(57)
Diabetes
(50)
Adult
(48)
Middle Aged
(47)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Insulin
(28)
Diabetes Mellitus
(25)
Internal Medicine
(23)
Aged
(22)
Diabetes. Impaired Glucose Tolerance
(21)
Endocrine Pancreas. Apud Cells
(21)
Endocrinopathies
(21)
Human Health And Pathology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Reduction of endoplasmic reticulum- mitochondria interactions in beta cells from patients with type 2 diabetes

Hope, hype and present limitations of hybrid closed loop systems for persons with type 1 diabetes

Human Pancreatic Islets React to Glucolipotoxicity by Secreting Pyruvate and Citrate

Performance and patients’ satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulceration

miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes

Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3

Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations

Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening

Prise de position de la Société francophone du diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2 - 2021

Development and validation of a Type 1 and Type 2 diabetes-specific patient-reported experience measure e-questionnaire: Diabetes reported experience measures (DREMS)

Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway

Histoire naturelle des cellules bêta au cours du diabète de type 1 : conséquences cliniques et possibilités thérapeutiques

Bilateral vertebral artery dissection revealing Cushing's syndrome

Évaluer le ressenti des hypoglycémies chez des personnes vivant avec un diabète de type 1 reste toujours nécessaire en pratique clinique

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports

Reduction of endoplasmic reticulummitochondria interactions in beta cells from patients with type 2 diabetes

Comment on Šoupal et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-up From the COMISAIR Study. Diabetes Care 2020;43:37-43

Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide

Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216-224

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics

Comment on Šoupal et al. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-up From the COMISAIR Study. Diabetes Care 2020;43:37–43/ Reply

A Cholera Toxoid-Insulin Conjugate as an Oral Vaccine against Spontaneous Autoimmune Diabetes

Suchergebnisse filtern